Background: In recent years, important progress has been made in effective stroke treatment, however, patients living in rural and remote areas have nil or very limited access to timely reperfusion therapies.
Background
Stroke is the second highest cause of death, disability, and dementia worldwide, [1] [2] [3] and prevalence is expected to increase due to the rising aged population in many countries. 4 Apart from considerable suffering for patients and their families, stroke also results in enormous costs for society, including those associated with loss of employment and long-term care expenses. 5, 6 Although acute ischemic stroke is a treatable disease, timely access to guideline-adherent acute reperfusion therapies is a major limitation for many areas of the world, especially in countries with large rural and remote areas, where the coverage of specialized stroke centers is very poor.
Treatment disparity for stroke patients living in rural regions
Within a single country, the rural setting and distances to the nearest stroke center are key factors in the delivery of time-sensitive stroke treatment. 7, 8 Reported times from symptom onset to admission to rural hospitals range from 5 to 30 h. 9, 10 These prehospital delays have subsequently been attributed as a major reason for the very low thrombolysis rates of 1-6% for patients in rural areas worldwide. [11] [12] [13] In Australia, only 3% of patients in rural areas were able to access a stroke unit in a timely manner, compared to 77% of patients in metropolitan areas.
14 Furthermore, patients living in rural areas are less likely to receive brain imaging within 24 h, carotid imaging, and consultations from neurologists. 15 This affects not only low-income countries but also those with middle-and high-incomes. 9 The US Get With The Guidelines-Stroke registry has identified arrival at a rural hospital as one factor associated with recombinant tissue plasminogen activator (rt-PA) treatment failure. 16 Even worse, the rural-urban disparity in rt-PA administration has increased in the last decades. 17 The treatment gap between metropolitan and rural is even more pronounced with endovascular treatment options for acute stroke. 18 This is due to the requirement for substantial and highly specialized training, technical resources, and concentrated peri-interventional services (neurosurgery, anesthesiology, and neurointensive care) to allow effective delivery of intra-arterial therapy (IAT) services. This complex infrastructure is available only at a few specialized stroke centers (comprehensive stroke centers, CSCs), which are almost exclusively located in metropolitan centers. 19 Patients living in rural and remote regions, therefore, have only limited access to IAT services in time. 20 However, it must be considered that for acute stroke patients from remote areas (10,000 inhabitants, Rural Remote and Metropolitan Areas classification, RRMAS 21 ) it is not only about faster treatment, but about getting any treatment, which could represent their only chance of recovery considering the latest DAWN recanalization trial results. 22 So far, recent efforts to improve this situation include use of telemedical technologies that allow remote regional hospitals to obtain expert support and guidance in thrombolytic treatment, thereby improving quality of stroke care, as has already been realized, for example, by the Melbournebased stroke telemedicine service (Victorian Stroke Telemedicine) a program accompanied by structured training of the first responders in remote areas. 23 
Mobile Stroke Unit concept
The Mobile Stroke Unit (MSU) concept is a recent development, which allows diagnosis and treatment of stroke patients in the prehospital setting. This is based on a specialized ambulance that is additionally equipped to allow prehospital imaging and triage, including a computed tomography (CT) scanner for multimodal imaging studies, point-of-care (POC) laboratory for blood tests required for treatment, 24, 25 and telemedicine connection to a stroke specialist.
Several studies have shown that use of an MSU significantly reduces time delays prior to thrombolysis. [26] [27] [28] [29] Additionally, the proportion of patients that are able to be treated within 60 min after stroke symptom onset (''the golden hour of stroke'') have risen dramatically, from 4% to 57%. 26 This is due not only to a reduction in transport times but also to the marked improvement in efficiency from involvement of a specialized multidisciplinary stroke team that operates aboard the MSU. 30 Another important benefit of MSU is the use of prehospital CT to allow triage of patients with largevessel occlusion (LVO) or hemorrhage to the closest center with IAT or neurosurgical capability. This reduces the time to treatment for these important interventions and avoids costly interhospital transfers. (Figure 2 ) AirMobile Stroke Unit (Air-MSU) could be equipped identically to an MSU ambulance, with multimodal imaging capabilities, a POC laboratory, and a telemedicine connection to the CSC so that stroke patients in remote regions could obtain diagnosis and treatment close at the emergency site. Thus, the Air-MSU approach is an extension of the MSU concept to another transport vehicle. Regarding the workflow, all diagnostic workups would be performed on the ground, directly at the pickup location. After an initial neurological assessment, CT scanning and POC laboratory testing would be performed on the ground. Telemedicine (video conferencing, exchange of videos of patient examination and CT images) would take place in parallel or shortly thereafter.
Technical solutions
Transferring the MSU concept to an aircraft may be realized, for example, by using a fixed-wing aircraft such as the International Journal of Stroke, 13 (6) Hawker 800 XP (BAE Systems, London, UK) or the Pilatus PC-24 (Pilatus Aircraft Ltd, Stans, Switzerland), that are already in use by the Royal Flying Doctor Service of Australia. Such Air-MSUs would have to carry, in addition to all of the usual medical equipment of a flying ambulance, (a) an accumulator-driven CT scanner allowing multimodal imaging (e.g., CereTom; Samsung Neurologica Corporation, Danvers, MA, USA), (b) a telemedicine system (e.g., MEYTEC GmbH, Werneuchen, Germany) enabling the transmission of digital imaging and communication data obtained by CT scanning or video of clinical examination to the hospital's picture archiving and communication system (PACS), and (c) a POC laboratory system for blood tests depending on local guidelines: blood count (e.g., pocH-100i; Sysmex Europe GmbH, Hamburg, Germany); international normalized ratio and activated partial thromboplastin time (e.g., Hemochron Jr. Signature; International Technidyne Corporation, Edison, NY, USA); and liver enzymes, creatinine level, and glucose concentration (e.g., Reflotron Plus V Clinical Chemistry Analyzer; Roche Diagnostics, Mannheim, Germany).
In addition, the Air-MSU would carry a lightweight patient stretcher with the ability to bring the patient into alignment for a CT scan, and at least three seats for the medical staff. Figure 1 shows a model of the Pilatus PC-24 cabin that was built up for the purpose of visualizing how the equipment could be positioned and how much working space remains for the medical staff. The geometry of the CT scanner allows only a positioning in the middle of the cabin's longitudinal axis, which means that the stretcher also needs to be positioned accordingly. This is rather unusual for fixedwing air ambulance aircraft. However, the cabin of the PC-24 offers enough space for medical staff to work around the patient from both sides. Design of an Air-Mobile Stroke Unit (Air-MSU), including a computed tomography (CT) scanner, a point-of-care (POC) laboratory and telemedicine equipment, a lightweight stretcher, and four additional seats for medical staff. As exemplary basis of such system, a Pilatus PC-24, which is used by the Royal Flying Doctor Service of Australia is shown.
In aviation, the weight-distribution and -limitation is crucial as it directly influences the flight performance of the respective aircraft. As the CT scanner represents a relatively heavy single item for a typical air ambulance aircraft, it should be placed as near to the center of gravity as possible. But the CT scanner will also block a big part of the cabin's cross-section, so to guarantee a smooth workflow only positioning in the front or the rear of the cabin seems reasonable. From these two options, the one closer to the center of gravity should be chosen. However, this option might not be available in the case that access to the cabin is only possible through one door in the front or rear of the cabin, leaving the respective other side as the only option to place the CT scanner (Figure 1 ). Nevertheless, it should be kept in mind that other equipment might have to be positioned in a way that the weight of the CT scanner is counterbalanced. In any event, because of the aforementioned influence on performance, it would be preferable to design the CT scanner as light and small as possible for an Air-MSU. One idea to achieve this even with, for example, the CereTom CT scanner is to use the auxiliary power unit, as power supply instead of the integrated batteries.
For a reliable and durable operation of the Air-MSU, mainly the CT scanner, but also the rest of the International Journal of Stroke, 13 (6) necessary equipment has to show resistance to vibration, humidity, and sudden loss of pressure, and exclude electromagnetic interference with the avionics of the aircraft. Therefore, a test period will be required and depending on the results, additional systems such as for vibrational damping may need to be developed. However, long-term routine experience with various MSUs, even under conditions of poor street quality, indicates that the CereTom scanner is highly resistant to vibrations. Also, cabin pressure in an Air-MSU is unlikely to affect the function of the scanner, that is, as the scanner is intended to be used exclusively on the ground. In general, it can be expected that technical advances, such as improved robustness and miniaturization seen in most fields of technology, will in time probably also affect CT imaging, which obviously depends on market forces.
A similar fixation with bolts like in the ground-bound MSU could be used to mount the CT scanner to the cabin floor. But it will need to be designed for higher loads because regulations demand that equipment withstands high G-forces in case of an emergency landing. In addition, these loads make it necessary that the cabin floor will have to be reinforced where the CT scanner is fixed. Furthermore, to get the CT scanner into a small fixed-wing aircraft like the PC-24, it will be necessary to dismantle the CT scanner and assemble it again in the cabin. In total, we expect an additional weight to the aircraft of approximately 400 kg, a feasible amount considering the maximum payload of air ambulance aircraft, which provide a cabin that is big enough to accommodate the scanner. Nevertheless, the impact of the additional payload on the available range needs to be considered when it comes to the question how big the area should be that is to be covered by the Air-MSU.
Alternatively, the same concept could also be realized by using a helicopter, although the space and weight restrictions may be more challenging than those of a fixed-wing aircraft.
Currently, apart from us also other groups are considering to transfer the MSU concept to helicopter solutions (e.g., Th. Lindner and H.-M. Lossius at University of Stavanger and Chr. Lund and M. Hov, University of Oslo, Norway).
A case study has shown that even the cabins of conventional emergency medical services (EMS) helicopters like the Augusta Westland 139 (Leonardo S.p.A., Rome, Italy) or the H155 (Airbus Helicopters, Marignane, France) do not provide enough height to accommodate the CereTom CT scanner. Furthermore, even if only equipped with what is absolutely necessary for an EMS mission, additional 400 kg would lead to a surpassing of their maximum take-off weight. As a result, a larger multi-mission helicopter like the Augusta Westland 101 (Leonardo S.p.A., Rome, Italy) or the NH90 (NHIndustries, Aix-en-Provence, France) may be needed. Those helicopters provide not only a sufficiently large cabin to accommodate the CereTom CT scanner but also offer high maximum payload, making an integration straightforward. A similar model like the one of the PC-24 but for the NH90 can be seen in Figure 2 . An additional advantage of such a helicopter is that it is much easier to load the patients into the cabin and bring them into correct alignment with the CT scanner, as they usually have a ramp in the rear of the cabin. This results in positioning the CT scanner in the front of the cabin as the only choice.
However, as they are not routinely used for EMS purposes, this approach would come with the additional investment costs of such a helicopter, and its higher weight would limit the options for landing on a hospital helipad. The damping of the CT scanner should also be done more carefully, as helicopters are usually a much bigger source of vibration than fixedwing aircrafts. The obvious advantage of using a helicopter instead of a fixed-wing aircraft is that no runway is needed but landing directly at the emergency site or hospital would be possible. Moreover, the cabin is usually wider, providing more space for medical staff to work around the patient. The fixed-wing aircraft, however, remains superior in range and speed, and might, therefore, reach some remote areas a helicopter cannot.
Different staffing options of an Air-MSU
Regarding the staffing, different options exist that depend on the size and level of competence of the regular flying doctor team. As a starting point under still experimental conditions staff consisting of a paramedic, a radiographer and a general practitioner trained in acute stroke medicine or even a neurologist with emergency medical training might be beneficial based on experiences in ground-bound MSUs. 31, 32 In addition, telemedical consultation including transfer of CT images of the Air-MSU to the next CSC supports the emergency team in diagnosis, treatment decision, and initiation, thereby allowing to reduce the size of the staff.
Different scenarios of Air-MSU missions
Two main scenarios can be anticipated in use of an Air-MSU in order to improve access to state-of-the-art stroke treatment in remote areas (Figure 3) .
In scenario 1, the Air-MSU, having been activated by the EMS dispatch center, reaches the patient at the emergency site, using the closest possible landing option. The Air-MSU thereby may either function as first responding EMS or takes over the stroke patient from the first responding regional EMS. Depending on International Journal of Stroke, 13 (6) the distance from the specific landing site and on the type of air transport used, an additional ambulance ride may be necessary. There, all stroke examinations (neurological examination, imaging, and POC laboratory testing) are performed already in the prehospital phase of stroke management, and, if indicated, intravenous (IV) thrombolysis is initiated in the field. Moreover, based on the clarification of the vascular cause directly at the emergency site, a correct triage decision about the appropriate target hospital can be made. In case of LVO or intracerebral hemorrhage, the Air-MSU may, after prenotification, transfer the patient directly to a CSC for required endovascular, neurosurgical, or neurointensive treatment. All other cases may be triaged to the nearest regional strokeready hospital.
In scenario 2, the patient has already been admitted to a hospital without specific stroke expertise. The Air-MSU team, alerted either by the EMS dispatch office or by the hospital team, would come to take over the specialized stroke management. This includes, apart from an eventually indicated IV thrombolysis, a vascular diagnostic workup by CT angiography and, eventually, CT perfusion, as precondition for a rational triage decision about whether or not the patient should be secondarily transferred to a CSC for IAT. Alternatively, in the rural hospital, the patient could, while the Air-MSU is still underway, obtain first neurological assessment and, after noncontrast imaging, thrombolytic treatment. After arrival, the Air-MSU would complement stroke management with vascular imaging as a precondition for a rational triage decision, and, if indicated, realizes the transport of the patient to the CSC for specialized stroke treatment.
Conclusion
Novel health care solutions are urgently needed that reduce the detrimental treatment gap for stroke patients living in rural and remote regions. This is especially true with regard to the poor access to timely reperfusion therapies outside of major metropolitan areas. The The airplane lands at a field close to the emergency site. At this location, the Air-MSU team either functions as first responding EMS unit or meets the regional EMS to take over specialized neurological assessment including imaging studies and laboratory tests. The patient may receive prehospital thrombolysis and based on the results of vascular imaging (CT angiography, CT perfusion) a decision between treatment in a comprehensive stroke center (CSC) versus a primary hospital or primary stroke center will be made. Scenario 2: The patient is first admitted to a regional primary hospital by the regular EMS. The Air-MSU, then, accesses the patient at this hospital and takes over specific stroke workup including vascular imaging. Depending on the results of these advanced diagnostic procedures the patient may, after eventually indicated IV thrombolysis, be either transported to a CSC for specialized acute stroke treatment or remains at the first admitting rural hospital.
International Journal of Stroke, 13 (6) paper focusing the still-unresolved problem of the detrimental undertreatment of stroke patients in remote regions presents a hypothetical Air-MSU concept that allows prehospital assessment, imaging, blood analysis, and specialized treatment by incorporating a portable CT scanner point-of-care laboratory unit, and telemedicine connection together with a stroke specialized team aboard an aircraft. This would allow overall access and dramatically reduced time delays for reperfusion therapies and enable correct prehospital triage to endovascular and neurosurgical centers, thereby reducing the treatment disparity for geographically isolated patients.
The cost-effectiveness of an Air-MSU is at this stage uncertain. Two preliminary estimations based on the first trials indicate that at least ground-based MSUs may be in fact cost-effective. 33, 34 However, for a more definite understanding of the economic impact of ground-based MSUs, large controlled studies are needed, such as the current BEST-MSU study coordinated in Houston, Texas, USA, which is expected to provide more robust evidence. 28 The costs of a 24/7 Air-MSU service are considerable. However, in contrast to the ground-based MSU, an Air-MSU would be able to cover a huge catchment area, thus greatly increasing the usage of the service. The costeffectiveness of an Air-MSU is difficult to predict, because it may be different in each region and country. Also, the willingness of relevant parties to spend the amount of money necessary to overcome the treatment disparity between urban and rural stroke patients may differ, and this difference in willingness also has ethical and political dimensions. Finally, recent developments, such as the introduction of endovascular stroke treatments, which are available only at CSCs located at larger cities, complicate these considerations. Finally, in specific settings, a more general use of an Air-MSU may be of medical and economic benefit. If equipped with more diagnostic tools such as a broader point-ofcare laboratory, and portable ECG, ultrasound or EEG devices, the emergency treatment and diagnosis-based triage of myocardial infarction, trauma or seizures and other general emergencies could be possible. Further research is needed to not only to establish optimal technical solutions and geographical implementation but also cost-effectiveness of such a concept.
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